Vigilancia del colangiocarcinoma en pacientes con colangitis esclerosante primaria: ¿es efectiva y está justificada?
Nataliya Razumilava, Gregory J. Gores – 10 November 2016
Lipid and copper metabolism in humans with wilson disease: Enigmatic relationship
Palittiya Sintusek, Anil Dhawan – 10 November 2016
Longterm renal allograft survival after sequential liver‐kidney transplantation from a single living donor
Kumiko Kitajima, Yuichi Ogawa, Katsuyuki Miki, Kotaro Kai, Akihito Sannomiya, Kazuhiro Iwadoh, Toru Murakami, Ichiro Koyama, Ichiro Nakajima, Shohei Fuchinoue – 10 November 2016 – Combined liver‐kidney transplantation (CLKT) is well established as a definitive therapy with the potential to provide complete recovery for certain liver‐kidney diseases, although the results might be contingent on the cause of transplantation.
¿Qué es la hipertensión portal no cirrótica idiopática?
Guadalupe García‐Tsao – 10 November 2016
Daño hepático debido al uso de suplementos nutricionales y de herbolario: revisión de componentes individuales
Elizabeth Zheng, Víctor Navarro – 10 November 2016
Effects of recipient size and allograft type on pediatric liver transplantation for biliary atresia
Sophoclis P. Alexopoulos, Victor Nekrasov, Shu Cao, Susan Groshen, Navpreet Kaur, Yuri S. Genyk, Lea Matsuoka – 10 November 2016 – The majority of pediatric patients with end‐stage liver disease receive a transplant with a whole liver (WL) allograft. However, smaller recipients with biliary atresia (BA) may have improved outcomes with deceased donor partial liver (DDPL) or living donor allografts. This study compares the national outcomes for liver transplantation in BA, with attention to the interaction between liver allograft type and recipient size.
Velpatasvir y sofosbuvir: ¿Por qué utilizar un fármaco nuevo si los antiguos funcionan bien?
Steven L. Flamm – 10 November 2016
Anticoagulación en la trombosis de la vena porta en la cirrosis
Nicolas M. Intagliata, Carlos N. Ferreira, Stephen H. Caldwell – 10 November 2016
Tratamiento personalizado del carcinoma hepatocelular basado en información molecular: perspectivas futuras
Nicolas Goossens, Yujin Hoshida – 10 November 2016